Metoclopramide Hydrochloride Accord Healthcare Ireland

Metoclopramide Hydrochloride, the active ingredient in Metoclopramide Hydrochloride Accord Healthcare Ireland, is a dopamine antagonist presented as an oral tablet for systemic use. It treats nausea, vomiting and gastroparesis in adults. GNH USA supplies Metoclopramide Hydrochloride Accord Healthcare Ireland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide Hydrochloride is an anti‑emetic dopamine antagonist used in gastrointestinal and postoperative settings. - Nausea and vomiting: reduces episodes of acute and chemotherapy‑induced nausea and vomiting. - Gastroparesis: improves gastric emptying and relieves symptoms of delayed gastric motility. - Post‑operative nausea: prevents or treats nausea following surgical procedures.

Metoclopramide Hydrochloride may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Drowsiness: mild sedation or fatigue. - Restlessness: feeling of inner tension or agitation. - Diarrhea: loose stools or increased bowel movements. - Extrapyramidal symptoms: transient muscle stiffness or tremor.

Serious or Rare Side Effects: - Tardive dyskinesia: persistent involuntary movements, especially with long‑term use. - Neuroleptic malignant syndrome: rare life‑threatening reaction with fever and muscle rigidity. - Severe allergic reaction: rash, swelling, or anaphylaxis.

When prescribing Metoclopramide Hydrochloride, clinicians should consider several safety precautions. - Contraindication: avoid in patients with known hypersensitivity to metoclopramide. - CNS disorders: use cautiously in individuals with Parkinson’s disease or seizure disorders. - Pregnancy: limit use during pregnancy; risk–benefit should be evaluated. - Breastfeeding: assess potential exposure to nursing infants before use. - Drug interactions: review concomitant medications that affect dopamine pathways. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in original packaging.

Metoclopramide Hydrochloride can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antipsychotics: may increase risk of extrapyramidal symptoms. - MAO inhibitors: can potentiate central nervous system effects. - CYP2D6 substrates: strong inhibitors may raise metoclopramide levels.

Moderate Interactions (Monitor Closely): - Opioids: additive sedation or constipation. - Anticholinergics: may reduce pro‑kinetic effect. - SSRIs/SNRIs: potential for serotonin syndrome when combined.